Академический Документы
Профессиональный Документы
Культура Документы
care
Supportive care
Pain Management in Cancer Patients
Prof Banjin
20.11.2019.
ESO 2000:
• Supportive Care:
– alleviates symptoms and complications of cancer
– reduces or prevents toxicities of treatment
– supports communication with patients about their
disease and prognosis
– allows patients to tolerate and benefit from active
therapy more easily
– eases emotional burden of patients and care givers
– helps cancer survivors with psychological and social
problems.
Managing symptoms and side effects
Types:
• Nociceptive : pain signals from nerve endings
• Neuropathic : damage to nerve fibres.
Descripatientive pain rating scales
• Numerical rating scale:
-Verbal: “What number describes your pain
from 0 (no pain) to 10 (worst pain you can
imagine)”?
- Written: “Circle the number that describes
your pain”
0 1 2 3 4 5 6 7 8 9 10
no pain worst pain you can imagine
Cancer Pain
• Nociceptive Somatic: intermittent to constant
sharp, knife-like, localized e.g. soft tissue
infiltration
• Nociceptive Visceral: constant/intermittent
crampy/squeezing poorly localized, referred
e.g. intra-abdominal mets
• Nociceptive Bony: constant, dull ache
localized, may have neuropathic features e.g.
vertebral metastasis pathologic fractures
Cancer Pain
• Neuropathic -Destruction/infiltration of nerves
a) dysesthetic: burning/tingling constant, radiates e.g.
post-herpetic neuralgia
b) neuralgic: shooting/stabbing shock-like/lancinating
paroxysmal e.g. trigeminal neuralgia
c) Chemotherapy induced Neuropathies :
Cisplatin,Oxaliplatin • Paclitaxel,Thalidomide •
Vincristine,Vinblastine
d) Surgical Neuropathies : Phantom Limb pain • Post
mastectomy syndrome • Post thoracotomy syndrome
Breakthrough “Incidental” pain
Nociceptive Agent
Opioids
Soft Tissue
Steroids
Visceral Surgery
Radiation Treatment
Opioid receptors
• Classically, opioids active on CNS receptors
mu (µ) kappa (κ) delta (δ) receptors
• Now found on:
• Peripheral Neurons
• Immune Cells
• Inflammed Tissue
• Respiratory Tissue
• GI Tract
Opioid Side Effects
Common Uncommon
• Constipation • Bad Dreams / Hallucinations
• Dry Mouth • Dysphoria / Delirium
• Nausea / Vomiting • Myoclonus / Seizures
• Sedation • Pruritus / Urticaria
• Sweats • Respiratory Depression
• Urinary Retention
Opioid-Induced Neurotoxicity (OIN)
• Neuropsychiatric syndrome
• Cognitive dysfunction
• Delirium
• Hallucinations
• Myoclonus/seizures
• Hyperalgesia/allodynia
BONE PAIN
PHARMACOLOGIC TREATMENT
• Opioids
• NSAIDs/steroids/Cox-2
inhibitors
• Bisphosphonates
-Pamidronate
-Clodronate
- Zoledronate
BONE PAIN
RADIATION TREATMENT
• 1. Single treatment (800 cGy)
• 2. Multiple fraction (200 cGy x 3-5)
• 3. Effective immediately
• 4. Maximal effect 4 - 6 weeks
• 5. 60-80% patients get relief
BONE PAIN
SURGICAL OPATIENTIONS
• 1. Pathologic # (splint, cast, ORIF)
• 2. Intramedullary support
• 3. Spinal cord decompression
• 4. Vertebral reconstruction
ADJUVANTS
NSAIDs
• Anti-inflammatory, anti-PEG
• S/E: gastritis/ulcer, renal failure
• ↑ K+ , platelet dysfunction
• Ibuprofen, naproxen
• Celecoxib
• Rofecoxib
• Meloxicam
• Valdecoxib
ADJUVANTS
STEROIDS
• ↓ inflammation
• ↓ edema
• ↓ spontaneous nerve depolarization
• Multipurpose
ADJUVANTS
ANTICONVULSANTS
• Gabapentin
• Lamotrigine
• Carbamazepine
• Valproic acid
ADJUVANTS
ANTIDEPRESSANTS
• Amitriptyline
• Nortriptyline
• Desipramine
• SSRIs: results disappointing
ADJUVANTS
NMDA RECEPTOR ANTAGONISTS
(N-methyl-D-aspartate)
• Ketamine
• Dextromethorphan
• Methadone
NEUROPATHIC PAIN
NON-PHARMACOLOGIC
• Radiation treatment
• Anaesthetic treatment
• Nerve Block
• Epidural Block
NEUROPATHIC PAIN
PHARMACOLOGIC TREATMENT
• Opioids
• Steroids
• Anticonvulsants
• TCAs (dysesthetic)
• NMDA receptor antagonists
• Anaesthetics
Key Points
• Current, accurate information
• Use available resources
• Involve family & caregivers
• Know patient knowledge base
• Address patient priorities first
• Small doses of useful info (e.g., S/E)
• Individualize to patient (social, education level
Conclusion
• Cancer pain can be from the cancer itself, or
from cancer-related treatments
• Can be somatic, visceral, or neuropathic
• Negative effects of cancer-related pain can
effect QOL, mortality
• Ask the patient about pain and REASSESS!
Conclusion
• Choose non-opioid / adjuvants carefully
paying close attention to side effect profile
• Use WHO ladder guidelines when titrating
pain medications
• Use long-acting opioids for chronic cancer
pain
• Recognize “4th step” in WHO ladder and
utilize your multidisciplinary resources
New adaptation of analgetic ladder
• Acute pain/ chronic pain without control/acute
crisis of chronic pain
• Step1-Nonopioid analgesics/ NSAIDS
• Step2-Weak opioids
• Step3-Strong opioids/Methadone/Oral
administration/Transdermal patch
• Step4-Nerve block/Epidurals/PCA pump/Neurolytic
block therapy/Spinal stimulators